» Articles » PMID: 39920515

Sheer Drop Ahead: Reviewing Sarcopenia Outcomes in Elderly Patients Undergoing Bariatric Surgery

Overview
Publisher Springer
Date 2025 Feb 7
PMID 39920515
Authors
Affiliations
Soon will be listed here.
Abstract

The global prevalence of obesity among elderly patients continues to rise. Despite the availability of new antiobesity medications, bariatric surgery remains an effective treatment option for carefully selected candidates. However, it is not risk-free, especially in a vulnerable population, predisposing to falls, fractures and sarcopenia. Following bariatric surgery, there is rapid loss of muscle mass, particularly within the first 3 months. Muscle quality, on the other hand, characterized by functionality and indirectly assessed through strength tests, appears to be preserved. This is attributed to reductions in ectopic intramuscular fat deposits. Strategies to mitigate muscle loss and functional impairment include combined exercises (resistive and aerobic training), adequate protein and vitamin D intake, beta-hydroxy-beta-methylbutyrate (HMB) supplementation, and testosterone replacement therapy for men with confirmed hypogonadism. It is important to emphasize that, to date, no specific trial has evaluated the current sarcopenia criteria in elderly patients undergoing bariatric surgery. Therefore, future studies are needed to assess this particularly vulnerable population, not only to monitor changes in muscular health, but also to develop strategies for preventing therapeutic inertia.

References
1.
Sabharwal S, Wilson H, Reilly P, Gupte C . Heterogeneity of the definition of elderly age in current orthopaedic research. Springerplus. 2015; 4:516. PMC: 4573966. DOI: 10.1186/s40064-015-1307-x. View

2.
Niccoli T, Partridge L . Ageing as a risk factor for disease. Curr Biol. 2012; 22(17):R741-52. DOI: 10.1016/j.cub.2012.07.024. View

3.
Lincoff A, Brown-Frandsen K, Colhoun H, Deanfield J, Emerson S, Esbjerg S . Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023; 389(24):2221-2232. DOI: 10.1056/NEJMoa2307563. View

4.
Stumpf M, Cercato C, de Melo M, Santos R, Mancini M . Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity. Eur J Prev Cardiol. 2023; 30(17):1895-1905. DOI: 10.1093/eurjpc/zwad280. View

5.
Halpern B, Mancini M, de Melo M, Lamounier R, Moreira R, Carra M . Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO). Arch Endocrinol Metab. 2022; 66(2):139-151. PMC: 9832894. DOI: 10.20945/2359-3997000000465. View